Generic Human Menopausal Gonadotropin (hMG) in Place of More Costly Follicle-Stimulating Hormone (FSH) for Routine Ovulation Induction


Purpose: A large part of infertility treatment involves the use of exogenous gonadotropins. The last decade has seen a progressive switch from human menopausal gonadotropin (hMG), the original gonadotropin product, to progressively more costly products, primarily or exclusively containing follicle-stimulating hormone (FSH). Though obviously at least in part… (More)
DOI: 10.1023/A:1009477523136

2 Figures and Tables


  • Presentations referencing similar topics